Global perspectives on vaccine financing.
Despite the great promise of immunization and recent progress in immunizing children throughout the developing world, a global crisis in vaccine R&D, supply and delivery is faced. This article reviews how the global US6 billion dollars vaccine market is structured and its attractiveness to vaccine suppliers, the international two-tiered pricing system in which high-income countries generate about 82% of vaccine revenues but represent only 12% of the doses, the impact of schedule divergence as high-income and developing countries introduce different vaccines, the role of the US government, and possible approaches to ameliorate the crisis.
Berman
Stephen
S
University of Colorado School of Medicine and The Childrens Hospital, 1056 E. 19th Ave., B032, Denver, CO 80218, USA. berman.stephen@tchden.org
Giffin
Robert B
RB
D019049:Developed Countries; D003906:Developing Countries; D015195:Drug Design; D004345:Drug Industry / Q000191:economics; D005380:Financing, Government; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D012109:Research Support as Topic; D014481:United States; D014612:Vaccines / Q000191:economics* / Q000600:supply & distribution
D014612:Vaccines